Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 40 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 9198915

    Methods involving aldose reductase inhibitors

    The Board of Regents of the University of Texas System · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  2. US 9192578

    Hot-melt extrusion of modified release multi-particulates

    The Board of Regents of the University of Texas System · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  3. US 9187523

    Substrate peptide sequences for plague plasminogen activator and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  4. US 9186400

    Compositions for stimulation of mammalian innate immune resistance to pathogens

    The Board of Regents of the University of Texas System · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  5. US 9186362

    Methods involving aldose reductase inhibitors

    The Board of Regents of the University of Texas System · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  6. US 9180102

    Methods for fabricating nano and microparticles for drug delivery

    The Board of Regents of the University of Texas System · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  7. US 9175058

    Soluble immune response suppressor polypeptides and treatment of multiple sclerosis and other autoimmune diseases

    The Board of Regents of the University of Texas System · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  8. US 9173975

    Reparative cell delivery via hyaluronic acid vehicles

    The Board of Regents of the University of Texas System · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  9. US 9175906

    Drug particles from freezing onto a surface

    The Board of Regents of the University of Texas System · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  10. US 9169509

    Topoisomerase 2b as a predictor of susceptibility to anthracycline-induced cardiotoxicity

    The Board of Regents of the University of Texas System · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  11. US 9163085

    Anti-OX40 antibodies and methods of treating cancer

    The Board of Regents of the University of Texas System · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  12. US 9162980

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  13. US 9161969

    Protection against influenza infection by granulocyte-macrophage colony stimulating factor

    The Board of Regents of the University of Texas System · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  14. US 9157916

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    The Board of Regents of the University of Texas System · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted

  15. US 9156787

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted

  16. US 9155703

    Method and process for the production of multi-coated recognitive and releasing systems

    The Board of Regents of the University of Texas System · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted

  17. US 9149489

    Inhibitors of glycolysis useful in the treatment of brain tumors

    The Board of Regents of the University of Texas System · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  18. US 9144605

    Recombinant rift valley fever virus encoding a dominant-negative inhibitor of DSRNA-dependent protein kinase in the NSS region

    The Board of Regents of the University of Texas System · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  19. US 9140698

    Modulating bacterial MAM polypeptides in pathogenic disease

    The Board of Regents of the University of Texas System · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  20. US 9127027

    Epoxyeicosatrienoic acid analogs and methods of making and using the same

    The Board of Regents of the University of Texas System · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  21. US 9125817

    Dual-cure dental resins and adhesives with increased cure and color-stability and low color

    The Board of Regents of the University of Texas System · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  22. US 9125846

    Antibodies that bind amyloid oligomers

    The Board of Regents of the University of Texas System · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  23. US 9119823

    Nitrite formulations and their use as nitric oxide prodrugs

    The Board of Regents of the University of Texas System · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  24. US 9119773

    Toroidal pharmaceutical formulations

    The Board of Regents of the University of Texas System · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.